* price as on January 01, 0001
India
Consensus ratings*: Buy 2 Hold 0 Sell 0
Previous target: 755
Up/downside: 143.8%
Reuters
Bloomberg: APEX IN
Market cap: US$138m
Rs9,989m
Average daily turnover: US$0.4m
Current shares o/s: 31.3m
Free float: 27.4%
*Source: Bloomberg

Key changes in this note

PAT estimates adjusted by 4.6% / 3.2% for FY23F/FY24F.

Revise target price to Rs780 (Rs755 earlier).

*Source: Bloomberg

Price performance
1M 3M 12M
Absolute (%) 4.4 14.0 26.4
Relative (%) (1.9) 3.8 17.3
Major shareholders
% held
Promoter & Promoter Group 72.6
Nippon Mutual Fund 5.3
Invesco Mutual Fund 1.5
Analyst(s)

Nitin AWASTHI

T (91) 22 4161 1550
E nitin.awasthi@incredcapital.com

The worst phase is finally over

Apex Frozen Foods reported a strong set of 1QFY23 numbers, in line with our expectations, because of logistics problems easing.

The transportation problem, which worsened in 4QFY22, eased to some extent in 1QFY23 and seems to be getting better.

Retain Add rating on the stock with a higher TP of Rs780 or 18x FY24F P/E.

Strong performance

Apex Frozen Foods Ltd (AFFL) came out with a strong set of numbers for 1QFY23, in line with our expectations. The tailwinds for the shrimp processing sector are strong. Demand from USA remained steady while in case of China it went through the roof. Production gained pace with demand after a long time. Logistics cost played spoilsport but has now eased and is expected to decline further. We expect AFFL to keep the movement going and post still better results in coming quarters. However, as demand still outpaces supply (shrimp supply), some raw material inflation is likely for shrimp processing going ahead. We expect AFFL to top 15,000mtpa in sales, in volume terms, in FY23F and 20,000mtpa sales in FY24F, even as recessionary fears loom large because of the shift in meat pricing dynamics. Shrimp was out of reach for most consumers a decade ago but has now become more affordable when compared with other protein foods.

Export-incentive math

Net duty drawback and the proportion of ROTDEP (Remission of Duties and Taxes on Export Products) received were the export incentives booked by AFFL in 1QFY23. ROTDEP incentive was not fully booked since the past six quarters. AFFL intends to book these incentives on a receipt basis, as per management, because of which we foresee the export incentive booking to turn lumpy in coming quarters.

Reiterate Add rating on the stock with higher target price of Rs780

We adjust our PAT estimates by 4.6% & 3.2% for FY23F & FY24F, respectively, based on 1QFY23 numbers. We retain Add rating on AFFL with a higher target price of Rs780 (Rs755 earlier) or 18x FY24F P/E. AFFL is likely to have an expanded capacity of 35,000mtpa by 4QFY23F. The undercurrent in terms of shrimp demand is strong, pricing power has returned for the company’s products, transportation problems seem to be stabilizing, and there should be a positive momentum in the stock price going ahead, in our view. Downside risks: Any drop in demand for shrimp and shrimp products, hindrance in supply of shrimp in domestic market, and any trade barriers imposed on India or the company’s products.

Financial Summary
Mar-20A Mar-21A Mar-22A Mar-23F Mar-24F
Revenue (Rsm) 8,271 8,185 9,142 11,568 14,709
Operating EBITDA (Rsm) 870 909 793 1,095 1,983
Net Profit (Rsm) 607 394 411 749 1,354
Core EPS (Rs) 19.4 12.6 13.1 24.0 43.3
Core EPS Growth (0.2%) (35.1%) 4.4% 82.3% 80.8%
FD Core P/E (x) 16.47 25.38 24.31 13.33 7.38
DPS (Rs) 2.0 1.8 2.6 2.4 4.3
Dividend Yield 0.63% 0.55% 0.82% 0.75% 1.36%
EV/EBITDA (x) 13.10 12.70 14.58 9.90 5.21
P/FCFE (x) 42.56 27.30 50.70 20.87 40.28
Net Gearing 35.5% 35.5% 33.2% 15.6% 5.2%
P/BV (x) 2.52 2.27 2.10 1.84 1.50
ROE 16.2% 9.4% 9.0% 14.7% 22.4%
% Change In Core EPS Estimates
InCred Research/Consensus EPS (x)
INCRED RESEARCH, COMPANY REPORTS, PRICED AS AT January 01, 0001
Figure 1: Quarterly summary

Rs m

1QFY23

4QFY22

%QoQ

1QFY22

%YoY

Revenue From Operations

3,058

2,068

47.9%

2,228

37.3%

Cost of Goods Sold

2,072

1,415

46.4%

1,550

33.7%

Employee Expenses

119

108

9.8%

119

-0.2%

Other Expenses

713

382

86.6%

469

52.0%

EBITDA

155

163

-4.6%

91

71.4%

Depreciation

51

46

12.6%

46

11.8%

EBIT

104

117

-11.2%

45

132.5%

Other Income

192

25

661.6%

47

309.7%

Interest Expenses

48

39

24.2%

45

8.3%

Profit Before Tax

248

104

139.4%

47

426.8%

Tax Expenses

62

30

105.0%

14

341.6%

Profit After Tax

185

73

153.8%

33

463.4%

Key Ratios

1QFY23

4QFY22

%QoQ

1QFY22

%YoY

EBITDA Margin

5.1%

7.9%

-279bp

4.1%

101bp

EBIT Margin

3.4%

5.7%

-227bp

2.0%

139bp

PBT Margin

8.1%

5.0%

310bp

2.1%

599bp

PAT Margin

6.1%

3.5%

253bp

1.5%

459bp

Tax Rate

25.2%

29.4%

-422bp

30.0%

-486bp

SOURCE: INCRED RESEARCH, COMPANY REPORTS  

 

Figure 2: Our revised earnings estimates

Rs m

Old estimates

New estimates

Change (%)

 

FY23F

FY24F

FY23F

FY24F

FY23F

FY24F

Revenue

11,006

14,317

11,568

14,709

5.1%

2.7%

EBITDA

1,205

1,929

1,095

1,983

-9.2%

2.8%

EBITDA Margin (%)

10.9%

13.5%

9.5%

13.5%

-149bp

1bp

PAT

716

1,312

749

1,354

4.6%

3.2%

EPS (Rs)

23

42

24

43

4.6%

3.2%

SOURCE: INCRED RESEARCH, COMPANY REPORTS  

 

Figure 3: One-year forward P/E
SOURCE: INCRED RESEARCH, COMPANY REPORTS  

 


 

BY THE NUMBERS

Profit & Loss
(Rs mn) Mar-20A Mar-21A Mar-22A Mar-23F Mar-24F
Total Net Revenues 8,271 8,185 9,142 11,568 14,709
Gross Profit 2,535 2,654 2,992 3,625 4,707
Operating EBITDA 870 909 793 1,095 1,983
Depreciation And Amortisation (146) (220) (185) (219) (192)
Operating EBIT 724 690 608 876 1,791
Financial Income/(Expense) 84 (133) (46) 134 39
Pretax Income/(Loss) from Assoc.
Non-Operating Income/(Expense)
Profit Before Tax (pre-EI) 808 557 562 1,010 1,830
Exceptional Items
Pre-tax Profit 808 557 562 1,010 1,830
Taxation (201) (163) (151) (260) (476)
Exceptional Income - post-tax
Profit After Tax 607 394 411 749 1,354
Minority Interests
Preferred Dividends
FX Gain/(Loss) - post tax
Other Adjustments - post-tax
Net Profit 607 394 411 749 1,354
Recurring Net Profit 607 394 411 749 1,354
Fully Diluted Recurring Net Profit 607 394 411 749 1,354
Cash Flow
(Rs mn) Mar-20A Mar-21A Mar-22A Mar-23F Mar-24F
EBITDA 870 909 793 1,095 1,983
Cash Flow from Invt. & Assoc.
Change In Working Capital (455) (546) (471) 560 (856)
(Incr)/Decr in Total Provisions
Other Non-Cash (Income)/Expense
Other Operating Cashflow
Net Interest (Paid)/Received 190 26 128 308 147
Tax Paid (163) (81) (116) (260) (476)
Cashflow From Operations 441 309 334 1,702 798
Capex (385) (125) (106) (724) (50)
Disposals Of FAs/subsidiaries
Acq. Of Subsidiaries/investments
Other Investing Cashflow
Cash Flow From Investing (385) (125) (106) (724) (50)
Debt Raised/(repaid) 178 182 (31) (500) (500)
Proceeds From Issue Of Shares
Shares Repurchased
Dividends Paid (75) (75) (135)
Preferred Dividends
Other Financing Cashflow (94) (146) (174) (174) (108)
Cash Flow From Financing 9 36 (205) (749) (744)
Total Cash Generated 66 220 23 229 4
Free Cashflow To Equity 235 366 197 479 248
Free Cashflow To Firm 56 184 228 979 748

BY THE NUMBERS…cont’d

Balance Sheet
(Rs mn) Mar-20A Mar-21A Mar-22A Mar-23F Mar-24F
Total Cash And Equivalents 72 99 74 304 308
Total Debtors 791 1,546 1,372 1,585 2,015
Inventories 1,840 1,612 2,028 1,268 1,612
Total Other Current Assets 698 603 700 885 1,126
Total Current Assets 3,402 3,860 4,175 4,042 5,061
Fixed Assets 2,802 2,504 2,360 3,110 2,969
Total Investments
Intangible Assets
Total Other Non-Current Assets 62 204 258 13 13
Total Non-current Assets 2,864 2,708 2,619 3,124 2,982
Short-term Debt 1,197 1,380 1,361 861 361
Current Portion of Long-Term Debt 40
Total Creditors 603 374 251 412 524
Other Current Liabilities
Total Current Liabilities 1,841 1,754 1,611 1,273 885
Total Long-term Debt 241 281 291 291 291
Hybrid Debt - Debt Component
Total Other Non-Current Liabilities
Total Non-current Liabilities 241 281 291 291 291
Total Provisions 225 135 137 173 220
Total Liabilities 2,307 2,170 2,039 1,737 1,396
Shareholders Equity 3,959 4,398 4,754 5,429 6,647
Minority Interests
Total Equity 3,959 4,398 4,754 5,429 6,647
Key Ratios
(Rs mn) Mar-20A Mar-21A Mar-22A Mar-23F Mar-24F
Revenue Growth (5.4%) (1.0%) 11.7% 26.5% 27.2%
Operating EBITDA Growth (2.9%) 4.6% (12.8%) 38.0% 81.1%
Operating EBITDA Margin 10.5% 11.1% 8.7% 9.5% 13.5%
Net Cash Per Share (Rs) (45.01) (49.98) (50.48) (27.14) (11.00)
BVPS (Rs) 126.69 140.74 152.14 173.71 212.71
Gross Interest Cover 6.83 4.33 3.50 5.02 16.55
Effective Tax Rate 24.9% 29.3% 26.9% 25.8% 26.0%
Net Dividend Payout Ratio 7.8% 9.9% 14.6% 7.4% 7.4%
Accounts Receivables Days 38.10 52.11 58.25 46.65 44.66
Inventory Days 92.38 113.92 108.03 75.73 52.54
Accounts Payables Days 29.22 32.25 18.54 15.22 17.08
ROIC (%) 15.4% 12.3% 10.0% 13.5% 27.8%
ROCE (%) 14.4% 12.0% 9.8% 13.5% 25.8%
Return On Average Assets 12.8% 10.7% 9.1% 12.6% 23.6%
Key Drivers
(Rs mn) Mar-20A Mar-21A Mar-22A Mar-23F Mar-24F
Outstanding Orderbook N/A N/A N/A N/A N/A
Order Book Depletion N/A N/A N/A N/A N/A
(Please link your key drivers and assumptions from EFA Sheet here) - Delete this line once done N/A N/A N/A N/A N/A
SOURCES: INCRED RESEARCH, COMPANY REPORTS

DISCLAIMER

This report (including the views and opinions expressed therein, and the information comprised therein) has been prepared by Incred Research Services Private Ltd.(formerly known as Earnest Innovation Partners Private Limited) (hereinafter referred to as “ IRSPL”). IRSPL is registered with SEBI as a Research Analyst vide Registration No. INH000007793. Pursuant to a trademark agreement, IRSPL has adopted “Incred Equities ” as its trademark for use in this report.

The term “IRSPL” shall, unless the context otherwise requires, mean IRSPL and its affiliates, subsidiaries and related companies. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject IRSPL and its affiliates/group companies to registration or licensing requirements within such jurisdictions.

This report is being supplied to you strictly on the basis that it will remain confidential. No part of this report may be (i) copied, photocopied, duplicated, stored or reproduced in any form by any means; or (ii) redistributed or passed on, directly or indirectly, to any other person in whole or in part, for any purpose without the prior written consent of IRSPL.

The information contained in this report is prepared from data believed to be correct and reliable at the time of issue of this report.

IRSPL is not required to issue regular reports on the subject matter of this report at any frequency and it may cease to do so or change the periodicity of reports at any time. IRSPL is not under any obligation to update this report in the event of a material change to the information contained in this report. IRSPL has not any and will not accept any, obligation to (i) check or ensure that the contents of this report remain current, reliable or relevant; (ii) ensure that the content of this report constitutes all the information a prospective investor may require; (iii) ensure the adequacy, accuracy, completeness, reliability or fairness of any views, opinions and information, and accordingly, IRSPL and its affiliates/group companies (and their respective directors, associates, connected persons and/or employees) shall not be liable in any manner whatsoever for any consequences (including but not limited to any direct, indirect or consequential losses, loss of profits and damages) of any reliance thereon or usage thereof.

Unless otherwise specified, this report is based upon reasonable sources. Such sources will, unless otherwise specified, for market data, be market data and prices available from the main stock exchange or market where the relevant security is listed, or, where appropriate, any other market. Information on the accounts and business of company(ies) will generally be based on published statements of the company(ies), information disseminated by regulatory information services, other publicly available information and information resulting from our research. Whilst every effort is made to ensure that statements of facts made in this report are accurate, all estimates, projections, forecasts, expressions of opinion and other subjective judgments contained in this report are based on assumptions considered to be reasonable as of the date of the document in which they are contained and must not be construed as a representation that the matters referred to therein will occur. Past performance is not a reliable indicator of future performance. The value of investments may go down as well as up and those investing may, depending on the investments in question, lose more than the initial investment. No report shall constitute an offer or an invitation by or on behalf of IRSPL and its affiliates/group companies to any person to buy or sell any investments.

The opinions expressed are based on information which are believed to be accurate and complete and obtained through reliable public or other non-confidential sources at the time made. (Information barriers and other arrangements may be established where necessary to prevent conflicts of interests arising. However, the analyst(s) may receive compensation that is based on his/their coverage of company(ies) in the performance of his/their duties or the performance of his/their recommendations. In reviewing this report, an investor should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest. Additional information is, subject to the duties of confidentiality, available on request.

The report is not a “prospectus” as defined under Indian Law, including the Companies Act, 2013, and is not, and shall not be, approved by, or filed or registered with, any Indian regulator, including any Registrar of Companies in India, SEBI, any Indian stock exchange, or the Reserve Bank of India. No offer, or invitation to offer, or solicitation of subscription with respect to any such securities listed or proposed to be listed in India is being made, or intended to be made, to the public, or to any member or section of the public in India, through or pursuant to this report.

The research analysts, strategists or economists principally responsible for the preparation of this research report are segregated from the other activities of IRSPL. Information barriers and other arrangements have been established, as required, to prevent any conflicts of interests.

The research analysts, strategists or economists principally responsible for the preparation of this research report are segregated from the other activities of IRSPL. Information barriers and other arrangements have been established, as required, to prevent any conflicts of interests.

IRSPL may have issued other reports (based on technical analysis, event specific, short term views etc.) that are inconsistent with and reach different conclusion from the information presented in this report.

Holding of Analysts/Relatives of Analysts, IRSPL and Associates of IRSPL in the covered securities, as on the date of publishing of this report

Analyst/ Relative Entity/ Associates
any financial interests in the company covered in this report (subject company) and nature of such financial interest NO NO
actual/beneficial ownership of 1% or more in securities of the subject company at the end of the month immediately preceding the date of publication of the research report or date of the public appearance; NO NO
any other material conflict of interest at the time of publication of the research report or at the time of public appearance NO NO
received any compensation from the subject company in the past twelve months for investment banking or merchant banking or brokerage services or investment advisory or depository or distribution from the subject company in the last twelve months for products/services other than investment banking or merchant banking or broker- age services or investment advisory or depository or distribution from the subject company in the last twelve months NO NO
managed or co-managed public offering of securities for the subject company in the last twelve months NO NO
received any compensation or other benefits from the subject company or third party in connection with the research report NO NO
served as an officer, director or employee of the subject company NO NO
been engaged in market making activity for the subject company NO NO
Analyst declaration
  • The analyst responsible for the production of this report hereby certifies that the views expressed herein accurately and exclusively reflect his or her personal views and opinions about any and all of the issuers or securities analysed in this report and were prepared independently and autonomously in an unbiased manner.
  • No part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations(s) or view(s) in this report or based any specific investment banking transaction.
  • The analyst(s) has(have) not had any serious disciplinary action taken against him/her(them). • The analyst, strategist, or economist does not have any material conflict of interest at the time of
  • publication of this report.
  • The analyst(s) has(have) received compensation based upon various factors, including quality, accuracy and value of research, overall firm performance, client feedback and competitive factors.

IRSPL and/or its affiliates and/or its Directors/employees may own or have positions in securities of the company(ies) covered in this report or any securities related thereto and may from time to time add to or dispose of, or may be materially interested in, any such securities.

IRSPL and/or its affiliates and/or its Directors/employees may do and seek to do business with the company(ies) covered in this research report and may from time to time (a) buy/sell the securities covered in this report, from time to time and/or (b) act as market maker or have assumed an underwriting commitment in securities of such company(ies), and/or (c) may sell them to or buy them from customers on a principal basis and/or (d) may also perform or seek to perform significant investment banking, advisory, underwriting or placement services for or relating to such company(ies) and/or (e) solicit such investment, advisory or other services from any entity mentioned in thisreport and/or (f) act as a lender/borrower to such company and may earn brokerage or other compensation. However, Analysts are forbidden to acquire, on their own account or hold securities (physical or uncertificated, including derivatives) of companies in respect of which they are compiling and producing financial recommendations or in the result of which they play a key part.